Samuel George Hansdak
Overview
Explore the profile of Samuel George Hansdak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iyadurai R, Peter J, Lenin A, Yadav B, Reginald A, Abhilash K, et al.
Med J Armed Forces India
. 2024 Dec;
80(Suppl 1):S217-S222.
PMID: 39734878
Background: Pyrethroid insecticides are commonly used insecticides. This study was undertaken to characterize the clinical profile and outcome of deliberate self-harm (DSH) with type 1 and type 2 pyrethroids and...
2.
Manesh A, George M, Palanikumar P, Nagaraj V, Bhanuprasad K, Krishnan R, et al.
Infect Dis Ther
. 2024 Sep;
13(11):2351-2362.
PMID: 39322920
Introduction: International guidelines recommend definitive combination antibiotic therapy for the management of serious infections involving carbapenem-resistant Acinetobacter (CRAB) species. The commonly available combination options include high-dose sulbactam, polymyxins, tetracyclines, and...
3.
Stanley N, Jeevan J, Yadav B, Gunasekaran K, Pichamuthu K, Chandiraseharan V, et al.
BMJ Open
. 2024 Apr;
14(4):e077428.
PMID: 38604633
Objectives: To estimate all-cause mortality in ventilator-associated pneumonia (VAP) and determine whether antibiotic duration beyond 8 days is associated with reduction in all-cause mortality in patients admitted with VAP in...
4.
S B M, Chacko B, Selvarajan S, Peter J, Geevar T, Dave R, et al.
Sci Rep
. 2024 Jan;
14(1):2011.
PMID: 38263377
Prospective and sequential evaluation of homeostatic changes leading to thrombosis across COVID 19 disease severity spectrum are limited. In this prospective observational study, haemostasis was evaluated in patients with mild,...
5.
Mathansingh A, Jose A, Fleming J, Abhilash K, Chandiraseharan V, Lenin A, et al.
Indian J Crit Care Med
. 2023 Jun;
27(6):397-402.
PMID: 37378371
Introduction: The effectiveness of gastric lavage in organophosphorus (OP) poisoning has not been established. We assessed the ability of gastric lavage to remove OP insecticides as a preliminary stage in...
6.
George T, Sharma P, Joy M, Seelan G, Sekar A, Gunasekaran K, et al.
Dialogues Health
. 2023 Jun;
2:100139.
PMID: 37317682
Background: The Covid-19 pandemic had a tremendous impact that caused significant morbidity, mortality, and financial stress for families. Our study aimed to determine the Out-of-pocket expenses and economic impact of...
7.
Arthur M, Pichamuthu K, Turaka V, Putta T, Jeeyavudeen M, Zachariah A, et al.
Postgrad Med J
. 2023 Apr;
PMID: 37117036
Background: This study determines the diagnostic utility of lung ultrasonography (LUS) in a medical ward in a developing country. In a low resource country like India, we hope that use...
8.
Kaswala C, Schmiedel Y, Kundu D, George M, Dayanand D, Devasagayam E, et al.
Int J Infect Dis
. 2022 Jul;
122:566-568.
PMID: 35811084
Objectives: The value of the "trace" result in Xpert Ultra for diagnosing active tuberculosis (TB) remains unclear. Our study evaluated the diagnostic accuracy of Xpert MTB/RIF Ultra (Xpert Ultra) (Cepheid,...
9.
Jacob M, Iyyadurai R, Jose A, Fleming J, Rebekah G, Zachariah A, et al.
Clin Toxicol (Phila)
. 2021 Oct;
60(4):464-471.
PMID: 34672857
Background: It is unclear if the clinical presentation of poisoning with type 1 and type 2 pyrethroid compounds is different. This study was undertaken to detail the clinical profile and...
10.
Mani S, Iyyadurai R, Mishra A, Manjunath K, Prasad J, Lakshmanan J, et al.
Int J Mycobacteriol
. 2021 Sep;
10(2):116-121.
PMID: 34558461
Background: Tuberculosis (TB) is a major global health problem, mainly in developing countries. Despite the availability of highly effective first-line antitubercular (ATT) drugs, ATT drug-induced liver injury (ATT DILI) leads...